1/25/2013

The NIH and the National Cancer Institute awarded Epic Sciences a Small Business Innovation Research grant to develop a test to detect and specify circulating tumor cells in lung cancer patients. Epic previously won a Phase I grant. The grants total $1.2 million.

Related Summaries